Resultado de búsqueda
Fosun International Limited is a Chinese multinational conglomerate holding company. [4] Founded in 1992 by Guo Guangchang and four others, the company is headquartered in Shanghai and was incorporated in Hong Kong in 2004. Its Co-CEOs are Chen Qiyu and Xu Xiaoliang.
- Fosun Pharma
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (trade name:...
- Fosun Pharma
See main article Fosun International Since 1994, Guo has been the chairman of Fosun Group and invested in insurance, pharmaceuticals and healthcare, property, steel, mining, retail, services, finance and other investment, and asset management, creating one of the largest non-state owned enterprises in China. [6]
Fosun International (復星國際有限公司, 复星国际有限公司) ( SEHK: 656) est le plus grand conglomérat privé de Chine continentale 3, 4. Son siège social est à Shanghai. Le groupe est divisé en trois grands domaines d'activités : santé (nutrition, environnement, recherche et développement en pharmacie ...
復星国際 （ふくせいこくさい、 中国語: 复星国际有限公司 、 英語: Fosun International Limited ）は、中国・ 上海市 黄浦区 にある 複合企業 、投資会社。 1992年創業。 復星集団（グループ）の基幹企業。 2015年時点でのグループ傘下の上場企業は21社 [3] 。 概説. 1992年に上海で、郭広昌（現・代表）、梁信軍（現・副代表）ら 復旦大学 の卒業生5人により調査会社として設立され、製薬、不動産などに多角化し、2007年に 香港証券取引所 メインボードに上場（復星国際00656.HK）。
In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2023, Fosun International’s total assets amounted to RMB808.4 billion; it received an AA MSCI ESG rating and was the only conglomerate in Greater China with such rating. 808.4. RMB808.4 billion Total assets
The globalization journey of Fosun started in 2007 when Fosun International was listed in Hong Kong. After nearly 16 years, Fosun has established businesses in more than 35 countries and regions (based enterprises with revenue exceeding RMB 100 million in such year).
